These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17640304)

  • 1. Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents.
    Shakoori A; Mai W; Miyashita K; Yasumoto K; Takahashi Y; Ooi A; Kawakami K; Minamoto T
    Cancer Sci; 2007 Sep; 98(9):1388-93. PubMed ID: 17640304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
    Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
    Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth.
    Kroon J; in 't Veld LS; Buijs JT; Cheung H; van der Horst G; van der Pluijm G
    Oncotarget; 2014 Oct; 5(19):8986-94. PubMed ID: 25344861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
    Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
    J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
    Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
    Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y
    Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells.
    Cao Q; Lu X; Feng YJ
    Cell Res; 2006 Jul; 16(7):671-7. PubMed ID: 16788573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of GSK-3beta enhances reovirus-induced apoptosis in colon cancer cells.
    Min HJ; Koh SS; Cho IR; Srisuttee R; Park EH; Jhun BH; Kim YG; Oh S; Kwak JE; Johnston RN; Chung YH
    Int J Oncol; 2009 Sep; 35(3):617-24. PubMed ID: 19639182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
    Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
    Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO; Oh JH; Son SM; Won D; Song HS; Han SB; Moon DC; Kang KW; Song MJ; Hong JT
    Cancer Biol Ther; 2011 Aug; 12(4):288-96. PubMed ID: 21613824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.
    Dickey A; Schleicher S; Leahy K; Hu R; Hallahan D; Thotala DK
    J Neurooncol; 2011 Aug; 104(1):145-53. PubMed ID: 21161565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear expression of glycogen synthase kinase-3β and lack of membranous β-catenin is correlated with poor survival in colon cancer.
    Salim T; Sjölander A; Sand-Dejmek J
    Int J Cancer; 2013 Aug; 133(4):807-15. PubMed ID: 23389968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.
    Schütz SV; Schrader AJ; Zengerling F; Genze F; Cronauer MV; Schrader M
    PLoS One; 2011; 6(9):e25341. PubMed ID: 21980429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct GSK-3β inhibition enhances mesenchymal stromal cell migration by increasing expression of β-PIX and CXCR4.
    Kim YS; Noh MY; Kim JY; Yu HJ; Kim KS; Kim SH; Koh SH
    Mol Neurobiol; 2013 Apr; 47(2):811-20. PubMed ID: 23288365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
    Gaisina IN; Gallier F; Ougolkov AV; Kim KH; Kurome T; Guo S; Holzle D; Luchini DN; Blond SY; Billadeau DD; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):1853-63. PubMed ID: 19338355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
    Yoshino Y; Ishioka C
    Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
    Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
    J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.